Drug Database
N02AA55 oxycodone and naloxone
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Myloxifin 10 mg/5 mg prolonged-release tablets
- POM Myloxifin 20 mg/10 mg prolonged-release tablets
- POM Myloxifin 40 mg/20 mg prolonged-release tablets
- POM Myloxifin 5mg/2.5mg prolonged release tablets
- POM Oxyargin 10 mg/5 mg prolonged-release tablets
- POM Oxyargin 20 mg/10 mg prolonged-release tablets
- POM Oxyargin 30 mg/15 mg prolonged-release tablets
- POM Oxyargin 40 mg/20 mg prolonged-release tablets
- POM Oxyargin 5 mg/2.5 mg prolonged-release tablets
- POM Targinact 10 mg / 5 mg prolonged release tablets
- POM Targinact 20 mg / 10 mg prolonged release tablets
- POM Targinact 40 mg / 20 mg prolonged release tablets
- POM Targinact 5 mg/2.5 mg prolonged-release tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).